BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3756876)

  • 1. Suppression of glioma growth in vitro and in vivo by glia maturation factor.
    Lim R; Hicklin DJ; Ryken TC; Han XM; Liu KN; Miller JF; Baggenstoss BA
    Cancer Res; 1986 Oct; 46(10):5241-7. PubMed ID: 3756876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of growth and of morphological characteristics in glioma cells by nerve growth factor and glia maturation factor.
    Marushige Y; Raju NR; Marushige K; Koestner A
    Cancer Res; 1987 Aug; 47(15):4109-15. PubMed ID: 3607753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoskeletal reorganization induced by nerve growth factor and glia maturation factor in anaplastic glioma cells.
    Marushige Y; Marushige K; Okazaki DL; Koestner A
    Anticancer Res; 1989; 9(4):1143-8. PubMed ID: 2683992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion.
    Ohnishi T; Arita N; Hayakawa T; Kawahara K; Kato K; Kakinuma A
    Biochem Biophys Res Commun; 1993 Jun; 193(2):518-25. PubMed ID: 8390244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of glial fibrillary acidic protein in human medulloblastoma cells treated with recombinant glia maturation factor-beta.
    Keles GE; Berger MS; Lim R; Zaheer A; Denton AL; Silber JR
    Oncol Res; 1992; 4(10):431-7. PubMed ID: 1292757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of differentiation-promoting response of astroglioma cells to glia maturation factor.
    Kato T; Ito J; Ishikawa K; Mizutani K; Tanaka R; Wakabayashi S; Horiuchi I; Kato K; Kano-Tanaka K
    Brain Res; 1984 May; 301(1):83-93. PubMed ID: 6329449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glia maturation factor (GMF) and the malignant proliferation of glioma cells].
    Ito J; Tanaka R; Kato T
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1955-63. PubMed ID: 6533679
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells.
    Dembinski TC; Leung CK; Shiu RP
    Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
    Saleh M; Stacker SA; Wilks AF
    Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of IL-24 gene expression on the growth of glioma cells in vitro and in vivo].
    Li WL; Shan BE; Yan YL; Zheng LF; Li QX; Zhou NJ; Zhao WQ
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):141-4. PubMed ID: 15946561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines.
    Zaheer A; Zaheer S; Sahu SK; Knight S; Khosravi H; Mathur SN; Lim R
    J Neurochem; 2007 Apr; 101(2):364-76. PubMed ID: 17250654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous immunoreactive glia maturation factor-like molecule in astrocytes and glioma cells.
    Lim R; Hicklin DJ; Ryken TC; Miller JF
    Brain Res; 1987 May; 430(1):49-57. PubMed ID: 3297257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ
    Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of MAP kinase (ERK1/ERK2) activity by phosphorylated glia maturation factor (GMF).
    Zaheer A; Lim R
    Biochemistry; 1996 May; 35(20):6283-8. PubMed ID: 8639570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of vaccinia virus in glioma model.
    Timiryasova TM; Li J; Chen B; Chong D; Langridge WH; Gridley DS; Fodor I
    Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo.
    Gabryś D; Dörfler A; Yaromina A; Hessel F; Krause M; Oertel R; Baumann M
    Strahlenther Onkol; 2008 Jan; 184(1):48-53. PubMed ID: 18188523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.
    Ke LD; Shi YX; Im SA; Chen X; Yung WK
    Clin Cancer Res; 2000 Jun; 6(6):2562-72. PubMed ID: 10873113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.